Delivery Order SPE2DB22D3301-SPE2DB25FZ1HD
- Not listed
- The Defense Logistics Agency awarded a $14,923.44 delivery order to AmerisourceBergen Drug Corp for Candesartan Cilexetil 32 mg tablets (90-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and...
- The Defense Logistics Agency awarded a delivery order valued at $10,881.52 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90-count bottles). This competitively awarded, firm fixed-price contract, with no set-aside designation, was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $11,562.81 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets in a quantity of 90 units. The contract was awarded on March 17, 2025, with an ultimate completion date of March 18, 2025, utilizing firm fixed price pricing with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,184.60 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 8, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's prime...
- The Defense Logistics Agency awarded a delivery order valued at $4,967.18 to AmerisourceBergen Drug Corp for Candesartan Cilexetil 32 mg tablets (90-count supply) on May 8, 2025, with an ultimate completion date of May 9, 2025. This is a firm fixed-price, non-set-aside contract with performance at the vendor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework with the Defense Logistics Agency....
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,950.76 for Candesartan Cilexetil 8 mg tablets (90-count) on September 2, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,584.07 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count) on June 18, 2025, with completion scheduled for June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a $60,591.71 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Candesartan Cilexetil 32 mg tablets in quantities of 90, with completion expected by September 5, 2025. This is a firm fixed price, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $74,555.12 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90-count units). This firm fixed-price, competitively awarded contract was issued on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count units) with a ceiling value of $59,408.56. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a non-competitive set-aside contract and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1HDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,083.66 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of September 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The firm's extensive portfolio of federal pharmaceutical contracts demonstrates its capability to fulfill diverse medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.1k | 9/19/25 |